Working… Menu

Adrecizumab Phase 1 Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02991508
Recruitment Status : Completed
First Posted : December 13, 2016
Last Update Posted : March 15, 2017
Adrenomed AG
Information provided by (Responsible Party):
Peter Pickkers, Radboud University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 22, 2016
Actual Study Completion Date : September 22, 2016